Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio

FARALLON CAPITAL MANAGEMENT LLC Performance:

2025 Q1: -4.51%YTD: -4.51%2024: 20.01%

Performance for 2025 Q1 is -4.51%, and YTD is -4.51%, and 2024 is 20.01%.

About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings

FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in SAN FRANCISCO, CA. On 20-Jul-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $41.2 Billions. In it's latest 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $17.9 Billions as of 31 Mar, 2025.

The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are MSFT, EXEL, UNH. The fund has invested 4.8% of it's portfolio in MICROSOFT CORP and 4.6% of portfolio in EXELIXIS INC.

The fund managers got completely rid off AIRBNB INC (ABNB), HASHICORP INC (HCP) and BRISTOL-MYERS SQUIBB CO (BMY) stocks. They significantly reduced their stock positions in HEALTHCARE RLTY TR (HR), ARROWHEAD PHARMACEUTICALS IN (ARWR) and DYNE THERAPEUTICS INC (DYN). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in INTRA-CELLULAR THERAPIES INC (ITCI), SOMNIGROUP INTERNATIONAL INC (TPX) and VERONA PHARMA PLC (VRNA). The fund showed a lot of confidence in some stocks as they added substantially to HEALTHEQUITY INC (HQY), GLOBUS MED INC (GMED) and GE HEALTHCARE TECHNOLOGIES I.

FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500

Our best estimate is that FARALLON CAPITAL MANAGEMENT LLC made a return of -4.51% in the last quarter. In trailing 12 months, it's portfolio return was 5.92%.

New Buys

Ticker	$ Bought
intra-cellular therapies inc	403,016,000
somnigroup international inc	79,415,400
verona pharma plc	68,886,000
alkermes plc	45,891,200
abbott labs	44,172,400
beta bionics inc	40,786,400
cardinal health inc	37,611,200
joyy inc	32,744,400

New stocks bought by FARALLON CAPITAL MANAGEMENT LLC

Additions

Ticker	% Inc.
healthequity inc	14,964
globus med inc	2,205
ge healthcare technologies i	333
vnet group inc	275
flutter entmt plc	167
forte biosciences inc	101
salesforce inc	62.55
genedx holdings corp	55.38

Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC

Reductions

Ticker	% Reduced
healthcare rlty tr	-99.63
arrowhead pharmaceuticals in	-97.49
dyne therapeutics inc	-95.64
soleno therapeutics inc	-94.44
silicon motion technology co	-92.94
zymeworks inc	-69.92
full truck alliance co ltd	-55.64
biodesix inc	-51.22

FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock

Sold off

Ticker	$ Sold
zto express cayman inc	-54,598,100
hashicorp inc	-220,757,000
matterport inc	-24,027,500
elevation oncology inc	-1,984,560
bristol-myers squibb co	-180,313,000
airbnb inc	-319,221,000
endeavor group hldgs inc	-57,422,900
gds hldgs ltd	-36,379,700

FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks

Sector Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 46.7% of it's holdings in Healthcare sector.

Sector	%
Healthcare	46.7
Technology	17.2
Industrials	10
Financial Services	8.3
Communication Services	8
Others	5.5
Real Estate	2.1
Consumer Defensive	1.5

Market Cap. Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 60% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	39.4
MID-CAP	32.9
MEGA-CAP	20.6
UNALLOCATED	5.5
SMALL-CAP	1.3

Stocks belong to which Index?

About 71% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
S&P 500	52.1
Others	29
RUSSELL 2000	18.9

Top 5 Winners (%)		%
BGNE	beigene ltd	47.4 %
SAGE	sage therapeutics inc	46.4 %
AXSM	axsome therapeutics inc	37.8 %
PGNY	progyny inc	29.5 %
PTGX	protagonist therapeutics inc	25.3 %

Top 5 Winners ($)		$
EXEL	exelixis inc	84.6 M
PTGX	protagonist therapeutics inc	59.6 M
MCK	mckesson corp	58.6 M
BSX	boston scientific corp	58.1 M
HIMS	hims & hers health inc	47.2 M

Top 5 Losers (%)		%
RVMD	revolution medicines inc	-76.5 %
IRWD	ironwood pharmaceuticals inc	-66.8 %
CGC	canopy growth corp	-66.8 %
SLDP	solid power inc	-62.2 %
CCCC	c4 therapeutics inc	-55.6 %

Top 5 Losers ($)		$
SRPT	sarepta therapeutics inc	-143.0 M
RVMD	revolution medicines inc	-112.5 M
CRM	salesforce inc	-111.2 M
MSFT	microsoft corp	-96.8 M
AON	aon plc	-96.4 M

FARALLON CAPITAL MANAGEMENT LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC

FARALLON CAPITAL MANAGEMENT LLC has 132 stocks in it's portfolio. About 36% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. EXEL was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.

Last Reported on: 15 May, 2025

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ABC	cencora inc	0.00	1,000	278,090	unchanged	0.00

ABNB	airbnb inc	0.00	0.00	0.00	sold off	-100

ABT	abbott labs	0.25	333,000	44,172,400	new

ACLX	arcellx inc	0.00	4,000	262,400	unchanged	0.00

ADI	analog devices inc	1.49	1,327,000	267,616,000	added	14.67

ADSK	autodesk inc	2.92	1,997,400	522,919,000	added	8.45

AGIO	agios pharmaceuticals inc	0.93	5,700,470	167,024,000	added	0.46

ALKS	alkermes plc	0.26	1,389,800	45,891,200	new

ALT	altimmune inc	0.00	27,600	138,000	unchanged	0.00

ALTR	altair engr inc	0.00	0.00	0.00	sold off	-100

AON	aon plc	2.11	1,361,740	378,337,000	reduced	-25.7

ARDX	ardelyx inc	0.00	23,000	112,930	unchanged	0.00

ARMK	aramark	3.13	16,242,000	560,674,000	added	42.34

ARQT	arcutis biotherapeutics inc	0.00	26,000	406,640	unchanged	0.00

ARWR	arrowhead pharmaceuticals in	0.00	15,800	201,292	reduced	-97.49

AXSM	axsome therapeutics inc	0.00	4,000	466,520	unchanged	0.00

BBIO	bridgebio pharma inc	1.10	5,731,000	198,121,000	added	36.62

BDSX	biodesix inc	0.01	1,859,310	1,162,440	reduced	-51.22

BEAM	beam therapeutics inc	1.08	9,928,110	193,896,000	added	20.5

BGNE	beigene ltd	0.00	1,100	299,387	unchanged	0.00